# Amgen Inc. – FDA Inspection, Nov 30, 2023

Source: https://www.keypedia.com/records/fda_inspections/amgen-inc/14d042ef-b33c-4176-b9f0-33cd3b204f96
Source feed: FDA_Inspections

> FDA inspection 1223903 of Amgen Inc., November 30, 2023. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1223903
- Company Name: Amgen Inc.
- Inspection Date: 2023-11-30
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Center: Human Drugs
- Office Name: Cincinnati District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1261008 - 2025-02-04
- [FDA Inspection 1228575 - 2024-01-17](https://www.keypedia.com/records/fda_inspections/amgen-inc/ef8f2368-9cc4-49d9-bb05-3c92b44b9d62)

## Related Officers

- [Andrew J. Barrowcliff](https://www.keypedia.com/people/andrew-j-barrowcliff/5dd49407-9028-4c84-9e86-3f0b6239538e)
- [Company Rep](https://www.keypedia.com/people/geoffrey-k-kilili/b00aeedf-95bd-4ccf-a23e-6e12e60249c4)

Company: https://www.keypedia.com/companies/amgen-inc/f15d2d1c-3482-417a-83de-0efa632c4095

Office: https://www.keypedia.com/offices/cincinnati-district-office/b67a0c35-82e3-4176-9039-988378f65c22